{"nct_id":"NCT04197479","title":"A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2019-12-16","start_date_type":"ACTUAL","primary_completion_date":"2023-01-06","primary_completion_date_type":"ACTUAL","completion_date":"2023-01-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MDGL"]}